Quantitative Systematic Strategies LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Quantitative Systematic Strategies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 06, 2020	SELL	$27.51 - $57.29 $103,190 - $214,894	-3,751 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$40.86 - $57.65 $188,487 - $265,939	-4,613 Reduced 55.15%	3,751 $204,000
Q3 2019 Nov 07, 2019	BUY	$37.38 - $49.47 $312,646 - $413,767	8,364 New	8,364 $349,000
Q3 2018 Nov 14, 2018	SELL	$32.79 - $43.0 $169,950 - $222,869	-5,183 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$23.62 - $42.29 $122,422 - $219,189	5,183 New	5,183 $205,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.79B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.